REQUEST A DEMO
Total
USD $0.00
Search more companies

Surcolombiana De Neurociencias S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Ambulatory Health Care Services
Full name: Surcolombiana De Neurociencias S.A.S. Profile Updated: March 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Surcolombiana De Neurociencias S.A.S. is an enterprise located in Colombia, with the main office in Neiva. It operates in the Ambulatory Health Care Services industry. The enterprise was incorporated on September 13, 2011. From the latest financial highlights, Surcolombiana De Neurociencias S.A.S. reported a net sales revenue drop of 74.29% in 2025. Its’ total assets recorded a negative growth of 50.12%. The net profit margin of Surcolombiana De Neurociencias S.A.S. increased by 18.64% in 2025.

Headquarters
Carrera 9 No 11 - 13 Centro Medico Y Emp
Neiva; Huila;

Contact Details: Purchase the Surcolombiana De Neurociencias S.A.S. report to view the information.

Basic Information
Registered Capital:
Purchase the Surcolombiana De Neurociencias S.A.S. report to view the information.
Financial Auditors:
Purchase the Surcolombiana De Neurociencias S.A.S. report to view the information.
Incorporation Date:
September 13, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Surcolombiana De Neurociencias S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-74.29%
Total Operating Revenue
-74.29%
Operating Profit
-64.39%
EBITDA
-64.39%
Net Profit/Loss for the Period
-52.38%
Total Assets
-50.12%
Total Equity
-50.01%
Operating Profit Margin
17.17%
Net Profit Margin
18.64%
Return on Equity (ROE)
-0.58%
Quick Ratio
369.14%
Cash Ratio
42.31%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?